HPVC2019-159 Biopharmaceuticals Long-Acting Granulocyte-Colony Stimulating Factor

Current Contract

Contract Start Date
28 Jun 2019
Contract End Date
27 Jun 2023
Option Periods
1 x 2 years

Description

Contract for the provision of long acting granulocyte colony-stimulating factor (G-CSF) to Victorian public hospitals and health services.

Additional Information

Contract Details

The Principal Period (2 years) commenced on 28 June 2019 until 27 June 2021. 
The first Contract Option period of two years has been executed - effective from 28 June 2021 until 27 June 2023.

Option Periods Remaining

1 x 2 Years

Categories

Category 1: Biopharmaceuticals Long-Acting Granulocyte Colony-Stimulating Factor

Notes:

Please favourite this contract to receive updates
Please review your account settings to ensure the notification frequency selected is adequate



Categories

1. Long-Acting Granulocyte Colony-Stimulating Factor